Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiformeGlioblastoma multiforme
Glioblastoma multiforme (GBM) is the most common and aggressive brain cancer, and despite treatment advances, patient prognosis remains poor. During…